Drug · DIN 02465256
BELBUCA
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since May 31, 2019; first marketed January 17, 2018.
- Drug Identification Number (DIN)
- 02465256
- Company (DIN owner)
- Purdue PharmaToronto, Ontario, Canada
- Schedule
- Narcotics (cdsa i)
- Dosage form
- Film (Soluble)
- Route
- Buccal
- Therapeutic class (ATC)
- Buprenorphine N02AE01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) | 300 MCG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 7, 2017: NOC 19768New Drug Submission (NDS) · Transfer of drug identification numbers
- June 21, 2017: NOC 19443New Drug Submission (NDS)
Other DINs named BELBUCA
- DIN 02465221 · Cancelled Post Market
- DIN 02465248 · Cancelled Post Market
- DIN 02465264 · Cancelled Post Market
- DIN 02465272 · Cancelled Pre Market
- DIN 02465280 · Cancelled Pre Market
- DIN 02465299 · Cancelled Pre Market